CYP4A22 and coronary artery disorder: Combined with previous studies and the results of this study, we speculate that the the mutant allele ‘A' of CYP4A22-rs12564525 may reduce the expression level of CYP4A22, thereby reducing the level of 20-HETE, and further reducing the risk of CHD in the study subjects.